Gene: AR ×
Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs864622007
rs864622007
AR
A 0.830 GeneticVariation CLINVAR

dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation UNIPROT

dbSNP: rs137852564
rs137852564
AR
A 0.800 CausalMutation CLINVAR

dbSNP: rs137852564
rs137852564
AR
0.800 GeneticVariation UNIPROT

dbSNP: rs137852578
rs137852578
AR
0.800 GeneticVariation UNIPROT

dbSNP: rs137852593
rs137852593
AR
0.740 GeneticVariation UNIPROT

dbSNP: rs137852581
rs137852581
AR
0.720 GeneticVariation UNIPROT

dbSNP: rs137852571
rs137852571
AR
0.710 GeneticVariation UNIPROT

dbSNP: rs1340026226
rs1340026226
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852567
rs137852567
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852580
rs137852580
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852582
rs137852582
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852583
rs137852583
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852584
rs137852584
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852591
rs137852591
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs138454018
rs138454018
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs78686797
rs78686797
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs868669253
rs868669253
AR
0.700 GeneticVariation UNIPROT

dbSNP: rs137852581
rs137852581
AR
0.720 GeneticVariation BEFREE SfaNI digestion of AR exon H DNA from normal but not from prostate cancer tissue indicated H874Y is a somatic mutation that occurred before the initial tumor transplant. 9092797

1997
dbSNP: rs137852593
rs137852593
AR
0.740 GeneticVariation BEFREE The present study indicates that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients. 11103816

2000
dbSNP: rs1034866440
rs1034866440
AR
0.040 GeneticVariation BEFREE The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer. 11847524

2002
dbSNP: rs137852569
rs137852569
AR
0.040 GeneticVariation BEFREE The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer. 11847524

2002
dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation BEFREE This mutant AR contains two mutations (L701H and T877A) and was previously reported as a high-affinity cortisol/cortisone responsive AR (AR(ccr)) isolated from the androgen-independent human prostate cancer cell lines MDA PCa 2a and 2b (Zhao et al.Nature Med.2000, 6, 703-6). 11906285

2002
dbSNP: rs137852578
rs137852578
AR
0.800 GeneticVariation BEFREE This mutant AR contains two mutations (L701H and T877A) and was previously reported as a high-affinity cortisol/cortisone responsive AR (AR(ccr)) isolated from the androgen-independent human prostate cancer cell lines MDA PCa 2a and 2b (Zhao et al.Nature Med.2000, 6, 703-6). 11906285

2002
dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation BEFREE The cortisol/cortisone-responsive AR (AR(ccr)) has two mutations (L701H and T877A) that were found in the MDA PCa human prostate cancer cell lines established from a castrated patient whose metastatic tumor exhibited androgen-independent growth. 11956172

2002